Early Registration Savings Deadline Expires In
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Delivered as a Hybrid Event
September 27-30, 2022Boston Convention and Exhibition CenterAdam WashburnSr. Advisor at Eli Lilly and Company
Profile
Dr. Adam Washburn is a Sr. Advisor at Eli Lilly and Company. His group supports bioproduct analytical development for monoclonal antibodies, peptides, and novel therapeutic modalities. His recent work has included analytical method development for AAV gene therapy.
Agenda Sessions
Transitioning from Monoclonal Antibody Separation Science to AAV Separation Science
, 10:15amView Session